local_hospital

Antes Zorg

Address
Maasstadweg 96, Rotterdam, The Netherlands

Antes Zorg - Treatment Resistant Depression Research

Antes Zorg is a specialized psychiatric research center focused on advancing treatment options for patients with severe and complex mood disorders. The center demonstrates particular expertise in investigating innovative therapeutic approaches for individuals who have not responded to conventional treatment modalities, contributing to the development of evidence-based protocols for challenging psychiatric conditions.

  • Treatment-resistant depression (TRD) intervention strategies
  • Comparative effectiveness research between pharmacological and neuromodulation therapies
  • Long-term maintenance treatment and relapse prevention in major depressive disorder

The center's research program includes comprehensive evaluation of oral esketamine therapy as an alternative to electroconvulsive therapy (ECT) in patients with non-psychotic therapy resistant unipolar depression. Through rigorous randomized controlled trials, Antes Zorg is examining both acute treatment response and long-term maintenance strategies, with the goal of optimizing individualized treatment pathways and improving outcomes for patients who have exhausted standard therapeutic options.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 271 other sites in The Netherlands

description
Trial volume
2
Outperforms 43% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
2sponsors
Outperforms 43% of sites

Therapeutic Area Benchmark — The Netherlands

Select a therapeutic area to compare against other sites in The Netherlands.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: The Netherlands

Market Share

Country: The Netherlands

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Antes Zorg

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Comparative Efficacy of Oral Esketamine Versus Electroconvulsive Therapy in Non-Psychotic Treatment-Resistant Unipolar DepressionUniversitair Medisch Centrum GroningenPhase IIINot Yet Recruiting

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Esketamine1Unknown

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.